Hazards of the First Nine Months: an Epidemiologist’s Nightmare

  • Richard Doll

Abstract

Few fields of medicine have seen such dramatic success as has been achieved by the combined efforts of obstetricians, paediatricians, medical officers of health, and laboratory workers to reduce the mortality of children. Vital records in England and Wales, which are typical of those of industrialized countries, show that, over the last 40 years, the stillbirth rate has been reduced by 68 per cent, infant mortality by 71 per cent, and the mortality of children at 1 to 9 years of age by 87 per cent. As a result, the odds on a foetus completing a decade of extra-uterine life, once it comes officially under starter’s orders 28 weeks from its mother’s last menstrual period, have shortened from 13 to 2 to 27 to 1.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Butler, N.R. and Alberman, E.D. (1969) Perinatal problems. Livingstone, Edinburgh.Google Scholar
  2. Butler, N.R. and Bonham, D.G. (1963) Perinatal mortality. Livingstone, Edinburgh.Google Scholar
  3. Butler, N.R., Goldstein, H. and Ross, E.M. (1972) Brit. med. J., 2, 127–130.PubMedCrossRefGoogle Scholar
  4. Cheeseman, E.A. and Walby, A.L. (1963) Ann. hum. Genet., Lond., 27, 23–29.CrossRefGoogle Scholar
  5. Chief Medical Officer (1971) On the state of the public health. Annual report of the Chief Medical Officer for the year 1970 H.M.S.O., London.Google Scholar
  6. Coffey, V.P. and Jessop, W.J.E. (1959) Lancet, 2, 935–938.PubMedCrossRefGoogle Scholar
  7. Coffey, V.P. and Jessop, W.J.E. (1963) Lancet, i, 748–751.CrossRefGoogle Scholar
  8. Crawford, M.D., Gardener, M.J. and Sedgwick, P.A. (1972) Lancet, I, 988–992.CrossRefGoogle Scholar
  9. David, T.J. (1972) New. Engl. J. Med., 287, 487–489.PubMedCrossRefGoogle Scholar
  10. Davie, R., Butler, N.R. and Goldstein, H. (1972) From birth to seven. Longmans, London.Google Scholar
  11. Elshove, J. (1970) Teratogene werking von fenytoine Proefschrift, Groningen.Google Scholar
  12. Elshove J. and Van Eck, J.H.M. (1971) Ned. T., Geneesk., 115, 1371–1375.Google Scholar
  13. Fedrick, J. (1970) Nature, 227, 176–177.PubMedCrossRefGoogle Scholar
  14. Fedrick, J. (1972) to be published.Google Scholar
  15. Fedrick, J. and Alberman, E.D. (1972) Brit. med. J., 2, 485–488.PubMedCrossRefGoogle Scholar
  16. Greenwald, P., Barlow, J.J., Nasca, P.C. and Burnett, W.S. (1971) New Engl. J. Med., 285, 390–392.PubMedCrossRefGoogle Scholar
  17. Gregg, N.M. (1941) Trans, ophthal. Soc. Aust., 3, 35.Google Scholar
  18. Hakosalo, J. and Saxen, L. (1971) Lancet, 2, 1346–1347.PubMedCrossRefGoogle Scholar
  19. Herbst, A.L. (1972) Statement presented before the United States Senate Committee on Labor and Public Welfare, Sub-committee on Health Diethylstilboestrol (DES) Hearings, July 10, 1972.Google Scholar
  20. Herbst, A.L., Ulfelder, H. and Poskanzer, D.C. (1971) New Engl. J. Med., 284, 878–881.PubMedCrossRefGoogle Scholar
  21. Hewitt, D., Sanders, B. and Stewart, A. (1966) Oxford Survey of Childhood Cancers: progress report IV Reliability of data reported by case and control mothers. Mon. Bull. Minist. Hlth., 25, 80–85.Google Scholar
  22. Jablon, S. and Kato, H. (1970) Lancet, 2, 1000–1003.PubMedCrossRefGoogle Scholar
  23. Janz, D. and Fuchs, U. (1964) Dtsch. med. Wcschr, 89, 241.CrossRefGoogle Scholar
  24. Knox, E. C. (1972) Brit. J. prev. soc. Med., 26, 219–223.Google Scholar
  25. Leck, I. (1963) Brit. J. prev. soc. Med., 17, 70–80.Google Scholar
  26. Lejeune, J., Turpin, R., Rethore, M-Q. and Mayer, M. (1960) Rev. franç. Étud. clin. biol., 5, 982.PubMedGoogle Scholar
  27. Lenz, W. (1962) Lancet, i, 45.CrossRefGoogle Scholar
  28. Lowe, C.R., Roberts, C.J. and Lloyd, S. (1971) Brit. med. J., 2, 357–361.PubMedCrossRefGoogle Scholar
  29. Mcbride, W.G. (1961) Lancet, 2, 1358.CrossRefGoogle Scholar
  30. MacMahon, B. (1962) J. nat. Cancer Inst., 28, 1173–1191.PubMedGoogle Scholar
  31. MacMahon, B. and Yen, S. (1971) Lancet, i, 31–33.CrossRefGoogle Scholar
  32. Melchior, J.C, Svensmark, O. and Trolle, D. (1967) Lancet, 2, 860–861.PubMedCrossRefGoogle Scholar
  33. Miller, R.W. and Blot, W.J. (1972) Lancet, 2, 784–787.PubMedCrossRefGoogle Scholar
  34. Naggan, L. (1969) Amer. J. Epidem., 89, 154–160.Google Scholar
  35. Naggan, L. and MacMahon, B. (1967) New. Engl. J. Med., 277, 1119–1123.PubMedCrossRefGoogle Scholar
  36. Newcombe, H.B. and McGregor, H.B. (1971) Lancet, 2, 1151–1152.PubMedCrossRefGoogle Scholar
  37. Penrose, L.S. (1957) J. ment. Defic. Res., I, 4–15.Google Scholar
  38. Pharaoh, P.O.D., Buttfield, I.H. and Hetzel, B.S. (1971) Lancet, i. 308–310.CrossRefGoogle Scholar
  39. Poswillo, D.E., Hamilton, W.J. and Sopher, D. (1972) Nature.Google Scholar
  40. Poswillo, D.E., Sopher, D. and Mitchell, S. (1972) Nature.Google Scholar
  41. Renwick, J.H. (1972) Brit. J. prev. soc. Med., 26, 67–88.Google Scholar
  42. Rogers, S.C. (1972) Lancet, i, 261.CrossRefGoogle Scholar
  43. Simpson, W.J. (1957) Amer. J. Obstet. Gynaec., 73, 8C8–815.Google Scholar
  44. Speidel, B.D. and Meadow, S.R. (1972) Lancet, 2, 839–843.PubMedCrossRefGoogle Scholar
  45. Stewart, A.M. and Kneale, G.W. (1970) Lancet, 1, 1185–1188.PubMedCrossRefGoogle Scholar
  46. Stewart, A., Webb, J., Giles, D. and Hewitt, D. (1956) Lancet, 2, 477.Google Scholar
  47. Stewart, A., Webb, J. and Hewitt, D. (1958) Brit. med. J., 1, 1495–1508.PubMedCrossRefGoogle Scholar
  48. Sullivan, F.M. (1972) Mechanisms of teratogenesis in Adverse Drug Reactions. Ed. D.J. Richards and R.J. Rondel. Churchill Livingstone, Edinburgh.Google Scholar
  49. Yerushalmy, J. (1964) Amer. J. Obstet. Gynec, 88, 505–518.PubMedGoogle Scholar
  50. Yerusalmy, J. (1971) Amer. J. Epidem., 93, 443–456.Google Scholar

Copyright information

© Irish Medical Association 1973

Authors and Affiliations

  • Richard Doll
    • 1
  1. 1.University of OxfordUK

Personalised recommendations